BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

News Science in Seattle
External News

Discriminative T Cell Recognition of Cross-Reactive Islet-Antigens Is Associated with HLA-DQ8 Transdimer–Mediated Autoimmune Diabetes

Read news ➡
News Logo Science Breaker
External News

Blood-eating cells: a defense or a threat?

Read news ➡
News King 5 News
External News

New Day NW: The Boeing Classic in Snoqualmie has hosted some of the greatest names in golf

Watch video ➡
News Science in Seattle
External News

Human CD4+CD103+ Cutaneous Resident Memory T Cells are Found in the Circulation of Healthy Individuals

Read news ➡
News Logo Carnegie Mellon University
News

Microscopy and VR Illuminate New Ways to Prevent and Treat Disease

Read More
News Logo Journal of Science Immunology
Press Release

Skin Immune Cell Discovery Challenges Beliefs About T Cells and How They Protect Against Infection

Read More
News Science in Seattle
External News

Dr. Cate Speake Talks Biorepositories and Immune Health

Read news ➡
News Logo Carnegie Mellon University
News

Scientists Employ VR and Microscopy to Prevent and Treat Illnesses

Read More
News Logo Gates Foundation GF
Press Release

Two-Step Expansion and VR Technique Enlarges Tiny Microbes, Illuminating New Ways to Prevent and Treat Disease

Read More
News Science in Seattle
External News

Pursuing a Revolution in IBD Treatment

Read blog ➡
News Logo Journal New England Journal of Medicine NEJM
News

Immunotherapy delays type 1 diabetes diagnosis in people at high risk

Read More
News Logo Journal New England Journal of Medicine NEJM
Press Release

Immunotherapy delays type 1 diabetes diagnosis in people at high risk

Read More
News Logo Journal New England Journal of Medicine NEJM
News

In milestone trial, experimental drug delays type 1 diabetes

Read More
News Logo The Scientist
External News

Novel Type of Immune Cell Discovered in Type 1 Diabetes Patients

Read more ➡
News Logo Parker Inst Cancer Immuno PICI
News

Parker Institute for Cancer Immunotherapy, JDRF and the Helmsley Charitable Trust Form Cancer and Diabetes Research Initiative

Read More